Rational choice of mucoactive phytopreparations in pediatrics: complex pharmacological action, efficacy, safety
Keywords:
Mucoactive phytopreparations, children, treatment, ivy extract, efficacy, safetyAbstract
Cough is one of the most common symptoms of acute respiratory viral infections in childhood. In the treatment of acute respiratory infections accompanied by cough in children, the main task is to stop the cough by improving the rheological properties of bronchial secretions for their early withdrawal. Cough can be effectively treated only by improving the discharge of mucus from the respiratory tract. For this purpose, mucoactive drugs are used: secretolytics, capable of thinning mucus (mucolytic action), and secretomotor drugs, which improve its output (expectorant effect). Among the many mucoactive drugs in pediatrics, preference is given to herbal drugs, which have a milder expectorant effect compared to synthetic drugs, and are better tolerated.
On the Ukrainian pharmaceutical market there is Gederin Ivy Syrup, a preparation with ivy extract. Among the complex of effects of the ivy leaf extract (expectorant, secretolytic, anti-inflammatory), the unique action that distinguishes it from other herbal and synthetic drugs is bronchospasmolytic one. Taking this into account, preparations with ivy extract can be recommended for respiratory infections accompanied by obstruction. These can be both acute and chronic conditions occurring with reversible narrowing of the airways. Due to its natural composition, the drug is safe. Side effects from Gederin Ivy syrup are very rare. In patients with hypersensitivity to the components of the drug some allergic reactions (mainly rash), as well as gastrointestinal disorders are possible. It should not be administered to patients suffering from fructose intolerance. Sorbitol, which is a component of the syrup, can cause a slight laxative effect.
Thus, the combination of such effects of ivy extract in the preparation Gederin Ivy – expectorant (mucokinetic and secretolytic), bronchospasmolytic and anti-inflammatory – predetermines its expressive clinical efficacy in the treatment of cough, as well as good tolerance. And this allows it to be widely used in the complex therapy of bronchitis in pediatric practice.
References
Antypkin YuH, Chumachenko NH, Lapshyn VF, Umanets TR. (2016). Dynamika zakhvoriuvanosti ta poshyrenosti bronkholehenevoi patolohii u ditei. Sovremennaya pediatriya. (74): 73—77. https://doi.org/10.15574/SP.2016.74.73
Baranov AA, Namazova LS. (2007). Effektivnost metodov alternativnoy terapii u detey. Pediatricheskaya farmakologiya. 4 (1): 37—41.
Bolbot YuK. (2015). Mukoliticheskaya terapiya respiratornyih zabolevaniy u detey. Child Health. (60): 98—102.
Celimzyanova LR, Promyislova EA, VishnYova EA. (2013). Fitoterapiya kashlya u detey. PF. 4 (128—130).
Chernikov VV. (2012). Primenenie preparatov rastitelnogo proishozhdeniya dlya lecheniya kashlya u detey. Pediatricheskaya farmakologiya. 9 (6): 100—104.
Davyidova IV. (2012). Fitoterapiya kashlya v rannem detskom vozraste. Pediatricheskaya farmakologiya. 9 (2): 107—109.
Ernst E. (2007). Herbal medicines: balancing benefits and risks. Novartis Found Symp. 282: 154-167; discussion 167-172, 212-218. https://doi.org/10.1002/9780470319444.ch11
Fazio S, Pouso J, Dolinsky D, Fernandez A, Hernandez M, Clavier G et al. (2009). Tolerance, safety and efficacy of Hedera helix extract in inflammatory bronchial diseases under clinical practice conditions: a prospective, open, multicentre postmarketing study in 9657 patients. Phytomedicine. 16 (1): 17-24. https://doi.org/10.1016/j.phymed.2006.05.003; PMid:16860549
Felix Holzinger, Jean-Francois Chenot. (2011). Systematic Review of Clinical Trials assessing the effectiveness of Ivy Leaf (Hedera Helix) for acute upper respiratory tract infections. Evidence-Based Complementary and Alternative Medicine. Article ID 382789. https://doi.org/10.1155/2011/382789; PMid:20976077 PMCid:PMC2957147
Greunke C, Hage-Hulsmann A, Sorkalla T, Keksel N, Haberlein F, Haberlein H. (2015). A systematic study on the influence of the main ingredients of an ivy leaves dry extract on the b2-adrenergic responsiveness of human airway smooth muscle cells. Pulm Pharmacol Ther. 31: 92-98. https://doi.org/10.1016/j.pupt.2014.09.002; PMid:25234924
Hocaoglu AB, Karaman O, Erge DO et al. (2012). Effect of Hedera helix on lung histopathology in chronic asthma. Iran J Allergy Asthma Immunol. 11: 316-323.
Hofmann D, Hecker M, Volp A. (2003, Mar). Efficacy of dry extract of ivy leaves in children with bronchial asthma - a review of randomized controlled trials. Phytomedicine. 10 (2-3): 213-220. https://doi.org/10.1078/094471103321659979; PMid:12725580
Janka Schulte2Michels, Anne Wolf, Stefan Aatz et al. (2016). α-Hederin inhibits G-protein-coupled receptor kinase 2-mediated phosphorylation of β-2adrenergic receptors. Phytomedicine. 23: 52-57. https://doi.org/10.1016/j.phymed.2015.12.001; PMid:26902407
Janka Schulte-Michels, Christina Keksel, Hanns Haberlein, Sebastian Franken. (2018). Anti-inflammatory effects of ivy leaves dry extract: influence on transcriptional activity of NFkB. Inflammopharmacology. 27 (2): 339-347. https://doi.org/10.1007/s10787-018-0494-9; PMid:29748881 PMCid:PMC6482290
Kompendium. (2019). ATC-klasyfikatsiia. Likarski preparaty. URL: https://compendium.com.ua/uk/atc/.
Kompendium. (2019). Hederyn Pliushch HEDERIN. Instruktsiia do zastosuvannia. OOO «DKP «Farmatsevticheskaya fabrika». URL: https://compendium.com.ua/info/171272/gederin/.
Korovina NA. (2000). Kashel u detey: posobie dlya vrachey. Moskva: Posad: 48.
Kryuchko TA, Tkachenko OYa, Vovk YuA. (2014). Lechenie kashlya u detey: ot raznoobraziya podhodov k logicheskomu vyivodu. Pediatriya. Vostochnaya Evropa. 3: 131–140.
Marquardt P, Kaft K, Nieber K. (2015). Clinical trials with herbal medicinal products in children: a literature analysis. Wien Med Wochenschr. 165 (11–12): 236–242. https://doi.org/10.1007/s10354-015-0373-6; PMid:26183729
Marushko YuV, Hracheva MG. (2015). Therapy in bronchopulmonary diseases associated with increased secretion of viscous sputum and impaired mucus transport. Zdorov’e rebenka. 1 (60): 135–139. doi: 10.22141/2224-0551.1.60.2015.74978.
Petrova SI, Panyutina YaV. (2006). Kashel u detey. Voprosyi prakticheskoy pediatrii. 1 (1): 94–98.
Prokhorovа MP. (2015). Differentiated approach to the treatment of cough in children. Immunology and Allergology: Science and Practice. (1): 112–118.
Promyislova EA, Selimzyanova LR, VishnYova EA. (2013). Preparatyi rastitelnogo proishozhdeniya pri kashle u detey. Pediatricheskaya farmakologiya. 10 (1): 74-76. https://doi.org/10.15690/pf.v10i1.592
Schmidt M, Thomsen M, Schmidt U. (2012). Suitability of ivy extract for the treatment of paediatric cough. Phytother Res. 26 (12): 1942-1947. https://doi.org/10.1002/ptr.4671; PMid:22532491
Sieben A, Prenner L, Sorkalla T, Wolf A, Jakobs D, Runkel F, Haberlein H. (2009). α-Hederin, but not hederacoside C and hederagenin from Hedera helix, affects the binding behaviour, dynamics and regulation of beta 2-adrenergic receptors. Biochemistry. 48: 3477-3482. https://doi.org/10.1021/bi802036b; PMid:19278262
Soroka ND, Korshunova EV, Ryabyih OV, Balatskaya GM, Kuznetsova NV, Belan EYu. (2010). Effektivnost i bezopasnost ingalyatsionnogo metoda lecheniya suhim ekstraktom listev plyuscha ostryih respiratornyih zabolevaniy u detey rannego vozrasta. Lechaschiy vrach. 6: 14-17.
Soroka ND. (2008). Mukoliticheskaya terapiya zatyazhnyih variantov techeniya zabolevaniy organov dyihaniya u detey. Voprosyi sovremennoy pediatrii. 7 (4): 111-114.
Suleyman H, Mshvildadze V, Gepdiremen A, Elias R. (2003). Acute and chronic antiinflammatory profile of the ivy plant, Hedera helix, in rats. Phytomedicine. 10: 370-374. https://doi.org/10.1078/0944-7113-00260; PMid:12834000
Tatochenko VK. (2001). Prakticheskaya pulmonologiya detskogo vozrasta. Spravochnik. Moskva: 268.
Tumanov VA, Pokanevich VV, Garnik TP, Frolov VM, Peresadin NA. (2012). Phytotherapy: application modern lines in medical practice and perspectives of the further development. Phitoterapiya. (1): 4–11.
Vishnyova EA, Torshhoeva RM, Alekseeva AA, Volkov KS. (2011). Vrachebnaya taktika pri kashle u rebenka. Pediatricheskaya farmakologiya. 8 (3): 95–97.
World Health Organization. (2010). WHO monographs on medicinal plants commonly used in the Newly Independent States (NIS). Geneva: WHO-Press: 464.
Downloads
Published
Issue
Section
License
The policy of the Journal “MODERN PEDIATRICS. UKRAINE” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
